Waldencast plc (NASDAQ:WALD) Shares Bought by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. grew its stake in shares of Waldencast plc (NASDAQ:WALD) by 16.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,895 shares of the company’s stock after acquiring an additional 9,130 shares during the period. Charles Schwab Investment Management Inc. owned about 0.05% of Waldencast worth $261,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of WALD. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Waldencast by 293.9% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock valued at $25,000 after buying an additional 5,114 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Waldencast in the 4th quarter worth about $42,000. Catalina Capital Group LLC grew its stake in Waldencast by 69.9% in the 4th quarter. Catalina Capital Group LLC now owns 27,102 shares of the company’s stock valued at $109,000 after acquiring an additional 11,154 shares during the last quarter. Barclays PLC increased its holdings in Waldencast by 301.4% during the 3rd quarter. Barclays PLC now owns 32,436 shares of the company’s stock valued at $117,000 after acquiring an additional 24,355 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its position in Waldencast by 52.0% during the third quarter. JPMorgan Chase & Co. now owns 43,250 shares of the company’s stock worth $157,000 after acquiring an additional 14,803 shares during the last quarter. Hedge funds and other institutional investors own 41.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on WALD shares. TD Cowen started coverage on Waldencast in a research report on Monday, December 16th. They set a “hold” rating and a $4.30 price target for the company. Telsey Advisory Group set a $5.00 price objective on Waldencast in a research note on Thursday, March 20th. Finally, DA Davidson reiterated a “buy” rating and set a $7.50 price objective on shares of Waldencast in a research report on Wednesday, March 19th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Waldencast currently has an average rating of “Moderate Buy” and an average target price of $5.56.

Waldencast Trading Down 1.0 %

Shares of WALD stock opened at $2.97 on Wednesday. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21. Waldencast plc has a one year low of $2.41 and a one year high of $7.54. The company has a 50 day moving average price of $3.25 and a 200 day moving average price of $3.42.

Waldencast Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.